KRMD 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-05-06

• The Company ended the first quarter of 2026 with $11.8 million in net revenues, a 22.1% increase compared to $9.6 million in the same period last year. Revenues were driven by growth in our core domestic and international business of 11.7% and 35.2%, respectively, along with an increase of 166.0% in…

• The Company imports certain materials and products that are subject to U.S. government tariffs and import duties. On February 20, 2026, a US federal court ordered the U.S. government to begin refunding certain tariffs. The Company believes that some of the tariffs it has paid may be eligible for ref…

• The following table summarizes our net revenues for the three months ended March 31, 2026, and 2025:

• Three Months Ended March 31, Change from Prior Year % of Net Revenues

• Total net revenues increased $2.1 million, or 22.1%, to $11.8 million for the three months ended March 31, 2026, as compared to $9.6 million in the prior year period. Domestic core revenues were $7.7 million, an increase of 11.7% over the prior year period, primarily due to higher consumable volumes…

相对上期删除的文字 · 来源:10-Q · 2025-11-12

• The Company ended the third quarter of 2025 with $10.4 million in net revenues, a 27.2% increase compared to $8.2 million in the same period last year. Revenues in our core business were $9.8 million, a 29.7% increase over the prior year period. Growth in our international core business of 229.6% wa…

• During the third quarter of 2025, we incurred tariff-related charges of $0.1 million. At this time, we expect tariff-related charges to have a gross margin impact of less than 100 basis points on an annualized basis.

• Three months ended September 30, 2025, compared to September 30, 2024

• The following table summarizes our net revenues for the three months ended September 30, 2025, and 2024:

• Three Months Ended September 30, Change from Prior Year % of Net Revenues

相对上期删除的文字 · 来源:10-Q · 2025-11-12

• 3.1(i) Certificate of Incorporation of KORU Medical Systems, Inc. (incorporated by reference to our Form 8-K filed with the SEC on May 17, 2023).

• 3.1(ii) Bylaws of KORU Medical Systems, Inc. (incorporated by reference to our Form 8-K filed with the SEC on May 17, 2023).